Human single chain antibodies against heparin: selection, characterization, and effect on coagulation
- PMID: 11895775
- DOI: 10.1182/blood.v99.7.2427
Human single chain antibodies against heparin: selection, characterization, and effect on coagulation
Abstract
Heparin, located in mast cells and basophilic granulocytes, is widely used as an anticoagulant. It belongs to a class of linear polysaccharides called glycosaminoglycans (GAGs). Using phage display technology, we have selected 19 unique human antiheparin antibodies. Some antibodies react almost exclusively with heparin, others also react with the structurally related heparan sulfate, and some with chondroitin sulfate. In all cases, sulfate groups are essential for binding. For activity of some antibodies, O-sulfation is more important than N-sulfation. Antibodies are reactive with heparin in mast cells. Each antibody showed a defined staining pattern on cryosections of rat kidney, pancreas, and testis. Enzymatic digestion with glycosidases on tissue sections further indicated that the antibodies are specific for GAGs. All antibodies recognize a unique epitope. The effect of the antibodies on heparin as an anticoagulant was also studied. There were 3 antibodies that were very effective inhibitors of heparin action in the activated partial thromboplastin time (APTT) clotting assay, and their effect was related to the amount of heparin bound. Some antibodies reacted strongly with the pentasaccharide, which interacts with antithrombin III. The human antibodies selected represent unique tools to study the structure, location, and function of heparin and related GAGs, and some may be used as blocking agents.
Similar articles
-
Construction and evaluation of an antibody phage display library targeting heparan sulfate.Glycoconj J. 2020 Aug;37(4):445-455. doi: 10.1007/s10719-020-09925-z. Epub 2020 May 28. Glycoconj J. 2020. PMID: 32468289 Free PMC article.
-
Phage display-derived human antibodies against specific glycosaminoglycan epitopes.Methods Enzymol. 2006;416:61-87. doi: 10.1016/S0076-6879(06)16005-X. Methods Enzymol. 2006. PMID: 17113860
-
Selection and characterization of a unique phage display-derived antibody against dermatan sulfate.Matrix Biol. 2006 Sep;25(7):457-61. doi: 10.1016/j.matbio.2006.06.003. Epub 2006 Jun 30. Matrix Biol. 2006. PMID: 16934446
-
Mechanisms for the anticoagulant effect of heparin and related polysaccharides.Nouv Rev Fr Hematol (1978). 1988;30(3):155-60. Nouv Rev Fr Hematol (1978). 1988. PMID: 2971155 Review.
-
Chemical derivatization as a strategy to study structure-activity relationships of glycosaminoglycans.Semin Thromb Hemost. 2002 Aug;28(4):335-42. doi: 10.1055/s-2002-34302. Semin Thromb Hemost. 2002. PMID: 12244480 Review.
Cited by
-
Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanoma.Cancer Immunol Immunother. 2003 Dec;52(12):780-3. doi: 10.1007/s00262-003-0421-8. Epub 2003 Sep 10. Cancer Immunol Immunother. 2003. PMID: 13680194 Free PMC article.
-
Conservation of anatomically restricted glycosaminoglycan structures in divergent nematode species.Glycobiology. 2016 Aug;26(8):862-870. doi: 10.1093/glycob/cww037. Epub 2016 Mar 13. Glycobiology. 2016. PMID: 26976619 Free PMC article.
-
Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains.Glycobiology. 2024 Jun 22;34(8):cwae046. doi: 10.1093/glycob/cwae046. Glycobiology. 2024. PMID: 38963938 Free PMC article.
-
Characterization of anticoagulant heparinoids by immunoprofiling.Glycoconj J. 2008 Feb;25(2):177-85. doi: 10.1007/s10719-007-9070-z. Epub 2007 Oct 2. Glycoconj J. 2008. PMID: 17909966 Free PMC article.
-
Peptide-displaying phage technology in glycobiology.Glycobiology. 2012 Mar;22(3):318-25. doi: 10.1093/glycob/cwr140. Epub 2011 Sep 19. Glycobiology. 2012. PMID: 21930649 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical